Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDE4A Biomarker for Eucrisa Response in Pediatric Atopic Dermatitis
NCT04023084Phase 4Completed
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Oct 2019
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
A Phase 4 trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Started Oct 2019; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04023084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023084.